Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Antibodies & Recombinant Proteins-Biosimilar Antibody-Varlilumab
Varlilumab

Chemical Structure : Varlilumab

CAS No.:

Varlilumab (Anti-human CD27 mAb, human IgG4P-Kappa; CDX-1127)

Catalog No.: PC-Ab1082Not For Human Use, Lab Use Only.

Varlilumab (CDX-1127) is a novel, first-in-class fully human IgG1 kappa anti-CD27 monoclonal antibody that acts as an agonist of CD27 by interaction with the CD70-binding site. Varlilumab (CDX-1127) stimulates the CD27 pathway, which results in T-cell activation and antitumor activity in tumor models..

Packing Price Stock Quantity
1 mg $358 In stock
5 mg $758 In stock
10 mg $1280 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Varlilumab (CDX-1127) is a novel, first-in-class fully human IgG1 kappa anti-CD27 monoclonal antibody that acts as an agonist of CD27 by interaction with the CD70-binding site. Varlilumab (CDX-1127) stimulates the CD27 pathway, which results in T-cell activation and antitumor activity in tumor models.

Physicochemical Properties

M.Wt
Formula Human IgG4P-Kappa
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

PBS, pH 7.0 Contains no stabilizers or preservatives

Chemical Name/SMILES

References

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: